ITFG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.831200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.092600E-01
Normal-vs-Stage2
5.373200E-01
Normal-vs-Stage3
7.001000E-01
Normal-vs-Stage4
1.210250E-01
Stage1-vs-Stage2
1.767790E-01
Stage1-vs-Stage3
6.248300E-02
Stage1-vs-Stage4
4.503000E-01
Stage2-vs-Stage3
2.002800E-01
Stage2-vs-Stage4
4.475700E-02
Stage3-vs-Stage4
3.409900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.836000E-01
Normal-vs-AfricanAmerican
1.999360E-01
Normal-vs-Asian
8.413200E-01
Caucasian-vs-AfricanAmerican
6.116400E-01
Caucasian-vs-Asian
9.712100E-02
AfricanAmerican-vs-Asian
5.947900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.099200E-01
Normal-vs-Female
4.472600E-01
Male-vs-Female
8.117600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.151200E-01
Normal-vs-Age(41-60Yrs)
2.833400E-01
Normal-vs-Age(61-80Yrs)
5.974400E-01
Normal-vs-Age(81-100Yrs)
9.325800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.344800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.748200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.002400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.756400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.678500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.551800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.962200E-01
Normal-vs-Daily Drinker
9.323400E-01
Normal-vs-Weekly Drinker
9.280800E-01
Normal-vs-Occasional Drinker
2.995400E-01
Normal-vs-Social Drinker
4.232400E-01
Non Drinker-vs-Daily Drinker
7.036400E-01
Non Drinker-vs-Weekly Drinker
5.036000E-01
Non Drinker-vs-Occasional Drinker
3.377600E-02
Non Drinker-vs-Social Drinker
1.768830E-01
Daily Drinker-vs-Weekly Drinker
7.435000E-01
Daily Drinker-vs-Occasional Drinker
2.379700E-02
Daily Drinker-vs-Social Drinker
1.193410E-01
Weekly Drinker-vs-Occasional Drinker
1.822370E-02
Weekly Drinker-vs-Social Drinker
1.038810E-01
Occasional Drinker-vs-Social Drinker
2.049400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.951370E-01
Normal-vs-Grade 2
1.003810E-02
Normal-vs-Grade 3
2.354400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.334800E-01
Grade 1-vs-Grade 3
8.953800E-01
Grade 1-vs-Grade 4
1.951370E-01
Grade 2-vs-Grade 3
7.187800E-02
Grade 2-vs-Grade 4
1.003810E-02
Grade 3-vs-Grade 4
2.354400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.849600E-01
Normal-vs-NonDiabetic
5.005400E-01
Diabetic-vs-NonDiabetic
6.200200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.058600E-01
Normal-vs-NoPancreatitis
5.229600E-01
Pancreatitis-vs-NoPancreatitis
8.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.950800E-01
Normal-vs-N1
5.246800E-01
N0-vs-N1
1.247040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.167400E-01
Normal-vs-TP53-NonMutant
4.876600E-01
TP53-Mutant-vs-TP53-NonMutant
3.663200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
